![Seong-Ho Choi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Ho Choi currently works at Double Investment Co. Ltd., as Chief Executive Officer.
Mr. Choi also formerly worked at VGXI, Inc., as Auditor.
Mr. Choi received his graduate degree from The University of Seoul.
| Bedrijven | Functie | Begin |
|---|---|---|
Double Investment Co. Ltd. | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| GENEONE LIFE SCIENCE, INC. | Comptroller/Controller/Auditor | 12-08-2025 |
VGXI, Inc.
 VGXI, Inc. Pharmaceuticals: MajorHealth Technology Manufactures deoxyribonucleic acid plasmids for human clinical trials | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
GeneOne Life Science, Inc.
 GeneOne Life Science, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
The University of Seoul
 The University of Seoul Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VGXI, Inc.
VGXI, Inc. Pharmaceuticals: MajorHealth Technology Manufactures deoxyribonucleic acid plasmids for human clinical trials | Health Technology |
Double Investment Co. Ltd. |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
